Literature DB >> 14697346

NIP1/XB51/NECAB3 is a potential substrate of Nek2, suggesting specific roles of Nek2 in Golgi.

Jae Cheal Yoo1, Jae Rak Chang, Sung Hwan Kim, Sung Key Jang, Debra J Wolgemuth, Kyungjin Kim, Kunsoo Rhee.   

Abstract

Nek2 is a mammalian protein kinase structurally homologous to Aspergillus NIMA. We previously observed that the Nek2 protein was localized in multiple sites within a cell in a cell cycle stage-specific manner. Such dynamic behavior of Nek2 allowed us to propose that Nek2 may be a mitotic regulator that is involved in diverse cell cycle events. To better understand the cellular processes in which Nek2 participates, we carried out yeast two-hybrid screening and isolated Nek2-Interacting Protein 1 (NIP1), which has been also named as XB51 and NECAB3. Physical interactions of Nek2 with NIP1 were confirmed. In fact, Nek2 can phosphorylate NIP1 in vivo. Immunostaining experiments revealed that NIP1 is a Golgi protein. These results propose a possible involvement of Nek2 in biological processes of the Golgi body, perhaps in relation to the inheritance of Golgi during mitosis or to cell cycle stage-specific regulation of exocytosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697346     DOI: 10.1016/j.yexcr.2003.09.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Centrobin/NIP2 is a microtubule stabilizer whose activity is enhanced by PLK1 phosphorylation during mitosis.

Authors:  Jungmin Lee; Yeontae Jeong; Saimi Jeong; Kunsoo Rhee
Journal:  J Biol Chem       Date:  2010-05-29       Impact factor: 5.157

2.  HSP70 binds to SHP2 and has effects on the SHP2-related EGFR/GAB1 signaling pathway.

Authors:  Jae Cheal Yoo; Michael J Hayman
Journal:  Biochem Biophys Res Commun       Date:  2006-11-03       Impact factor: 3.575

3.  NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells.

Authors:  Hiroki J Nakaoka; Toshiro Hara; Seiko Yoshino; Akane Kanamori; Yusuke Matsui; Teppei Shimamura; Hiroshi Sato; Yoshinori Murakami; Motoharu Seiki; Takeharu Sakamoto
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

Review 4.  Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development.

Authors:  Dibyendu Dana; Tuhin Das; Athena Choi; Ashif I Bhuiyan; Tirtha K Das; Tanaji T Talele; Sanjai K Pathak
Journal:  Molecules       Date:  2022-01-06       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.